Pfizer plays hardball in weight-loss drug fight
FT News Briefing
00:00
Why MetSera Matters for Weight-Loss Drugs
Marc prompts context and Oliver explains MetSera's pipeline and why next-generation obesity treatments are central to investor focus.
Play episode from 04:14
Transcript
